
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Cell & Tissue Banking Applications, Clinical Application, Research Applications), End-User - Global Forecast 2024-2030
Description
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Cell & Tissue Banking Applications, Clinical Application, Research Applications), End-User - Global Forecast 2024-2030
The Stem Cell Manufacturing Market size was estimated at USD 2.74 billion in 2023 and expected to reach USD 3.08 billion in 2024, at a CAGR 12.65% to reach USD 6.33 billion by 2030.
Global Stem Cell Manufacturing Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Stem Cell Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Stem Cell Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Stem Cell Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Anterogen Co., Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, CellGenix GmbH, Corning Incorporated, Danaher Corporation, Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, HiMedia Laboratories, JCR Pharmaceuticals Co., Ltd., Lonza Group AG, and Merck Group.
Market Segmentation & Coverage
This research report categorizes the Stem Cell Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Consumables
Culture Media
Instruments
Bioreactors & Incubators
Cell Sorters
Stem Cell Lines
Embryonic Stem Cells
Hematopoietic Stem Cells
Induced Pluripotent Stem Cells
Mesenchymal Stem Cells
Multipotent Adult Progenitor Stem Cells
Neural Stem Cells
Application
Cell & Tissue Banking Applications
Clinical Application
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy
Research Applications
Drug Discovery & Development
Life Science Research
End-User
Academic Institutes, Research Laboratories & Contract Research Organizations
Cell & Tissue Banks
Hospitals & Surgical Centers
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Stem Cell Manufacturing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Stem Cell Manufacturing Market?
3. What are the technology trends and regulatory frameworks in the Stem Cell Manufacturing Market?
4. What is the market share of the leading vendors in the Stem Cell Manufacturing Market?
5. Which modes and strategic moves are suitable for entering the Stem Cell Manufacturing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
198 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Stem Cell Manufacturing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Surge in awareness on therapeutic potency of stem cell products
- 5.1.1.2. Increasing investments in stem-cell based research globally
- 5.1.1.3. Favorable regulatory framework in developing economies for stem cell research
- 5.1.2. Restraints
- 5.1.2.1. High cost involved in stem cell manufacturing
- 5.1.3. Opportunities
- 5.1.3.1. Robust research and development activities in pharmaceutical and biotechnology sector
- 5.1.3.2. Technological advancements in stem cell manufacturing
- 5.1.4. Challenges
- 5.1.4.1. Concerns over technical limitations involved in manufacturing set-up and socio-ethical issues
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Stem Cell Manufacturing Market, by Product
- 6.1. Introduction
- 6.2. Consumables
- 6.3.1. Culture Media
- 6.3. Instruments
- 6.4.1. Bioreactors & Incubators
- 6.4.2. Cell Sorters
- 6.4. Stem Cell Lines
- 6.5.1. Embryonic Stem Cells
- 6.5.2. Hematopoietic Stem Cells
- 6.5.3. Induced Pluripotent Stem Cells
- 6.5.4. Mesenchymal Stem Cells
- 6.5.5. Multipotent Adult Progenitor Stem Cells
- 6.5.6. Neural Stem Cells
- 7. Stem Cell Manufacturing Market, by Application
- 7.1. Introduction
- 7.2. Cell & Tissue Banking Applications
- 7.3. Clinical Application
- 7.4.1. Allogeneic Stem Cell Therapy
- 7.4.2. Autologous Stem Cell Therapy
- 7.4. Research Applications
- 7.5.1. Drug Discovery & Development
- 7.5.2. Life Science Research
- 8. Stem Cell Manufacturing Market, by End-User
- 8.1. Introduction
- 8.2. Academic Institutes, Research Laboratories & Contract Research Organizations
- 8.3. Cell & Tissue Banks
- 8.4. Hospitals & Surgical Centers
- 8.5. Pharmaceutical & Biotechnology Companies
- 9. Americas Stem Cell Manufacturing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Stem Cell Manufacturing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Stem Cell Manufacturing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AbbVie Inc.
- 13.1.2. Anterogen Co., Ltd.
- 13.1.3. Becton, Dickinson and Company
- 13.1.4. Bio-Rad Laboratories, Inc.
- 13.1.5. Bio-Techne Corporation
- 13.1.6. CellGenix GmbH
- 13.1.7. Corning Incorporated
- 13.1.8. Danaher Corporation
- 13.1.9. Eppendorf AG
- 13.1.10. Fujifilm Holdings Corporation
- 13.1.11. Getinge AB
- 13.1.12. HiMedia Laboratories
- 13.1.13. JCR Pharmaceuticals Co., Ltd.
- 13.1.14. Lonza Group AG
- 13.1.15. Merck Group
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. STEM CELL MANUFACTURING MARKET RESEARCH PROCESS
- FIGURE 2. STEM CELL MANUFACTURING MARKET SIZE, 2023 VS 2030
- FIGURE 3. STEM CELL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. STEM CELL MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. STEM CELL MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. STEM CELL MANUFACTURING MARKET DYNAMICS
- FIGURE 7. STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. STEM CELL MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. STEM CELL MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. STEM CELL MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES STEM CELL MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEM CELL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. STEM CELL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. STEM CELL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.